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Objective: Recently, the MRI Osteoarthritis Knee Score (MOAKS), a new semi-quantitative magnetic
resonance imaging (MRI) scoring tool, was introduced by a panel of experienced researchers in osteo-
arthritis (OA). The MOAKS is primarily applicable to quantify OA status, since the interpretation of change
in the MOAKS features was not described. In order to enable longitudinal evaluation, we propose deﬁ-
nitions for progression and improvement of the main MOAKS features.
Method: Clear deﬁnitions for progression and improvement of the main MOAKS features are given in this
brief report. 687 baseline and 30 months follow-up MRIs of the knees of 348 overweight and obese
middle-aged women, free of OA at baseline, were scored using the MOAKS. Baseline prevalence and the
change of MOAKS features after 30 months follow-up, based on our deﬁnitions for progression and
improvement, are presented.
Results: The proposed deﬁnitions showed 3% to 23% progression and 0% to 11% improvement in the
MOAKS features during the 30 months follow-up. Overall, progression rates were higher in the medial
than in the lateral tibiofemoral (TF) joint. Progression of bone marrow lesions (BMLs) and cartilage
defects was highest in the patellofemoral (PF) joint. Inter-rater reliability of the MOAKS scores was
moderate to nearly perfect (PABAK 0.77e0.88), with high percentage of agreement overall (89e94%).
Conclusion: This brief report presents deﬁnitions for progression and improvement of the main MOAKS
features for the longitudinal evaluation of knee OA features on MRI. We advocate uniform usage of the
proposed deﬁnitions across studies, but welcome suggestions for optimization.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
In recent years, magnetic resonance imaging (MRI) has
demonstrated its relevance for the evaluation of structural changes
during the development and progression of knee osteoarthritis
(OA)1. Semi-quantitative scoring of MRI OA features has shown to
be a valid tool for this evaluation1. For this purpose, several semi-
quantitative scoring methods have been described, such as the
KOSS2, WORMS3 and BLOKS4.: J. Runhaar, Department of
nter, PO-box 2040, 3000 CA
: 31-10-7044766.
aar), d.schiphof@erasmusmc.
r), m.reijman@erasmusmc.nl
.A. Bierma-Zeinstra), e.oei@
ternational. Published by Elsevier LRecently, a panel of experienced researchers on semi-
quantitative MRI scoring of OA features re-evaluated all available
scoring systems. The panel stated that: “these tools have under-
done unpublished iterations that havemade it difﬁcult for the naïve
reader to determine the differences between original instrument
description and that which has been used”5. This effort resulted in
the MRI Osteoarthritis Knee Score (MOAKS) which was advocated
as an evolved semi-quantitative tool based on the authors'
knowledge and experience5.
The MOAKS, as published, is primarily applicable to quantify
disease status. Since the interpretation of the change of the MOAKS
features over time is not described by the authors, progression or
improvement of MOAKS features is hard to quantify. However,
change of MOAKS features seems to be an important measure for
the monitoring of knee OA, since MOAKS is advocated to be the tool
of choice for semi-quantitative analyses of knee OA. For proper
comparison between studies and in order to enable future meta-td. All rights reserved.
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change of the MOAKS features. These deﬁnitions need to be used
consistently by all researchers reporting on the change of MOAKS
features over time. Therefore, this work was conducted as an effort
to propose clear deﬁnitions for the progression and improvement
of the most important MOAKS features. We used baseline and 30
months follow-up data of a high-risk cohort of middle-aged over-
weight and obese women without knee OA at baseline to illustrate
the numbers associated with these deﬁnitions.
Methods
Training
An experienced musculoskeletal radiologist (EO; 10 years of
experience with musculoskeletal MRI in clinical and research set-
tings) trained all ﬁve readers (JR, DS, BvM, PvdP and DvE) in the use
of MOAKS. Before the training, the published MOAKS scoring sys-
tem was discussed among our research team and additional infor-
mation was obtained from the original authors for clariﬁcation of
certain features. Next, all features were thoroughly discussed dur-
ing four meetings. Between sessions, several MRIs of ongoing
studies not presented here were scored by all trainees and these
were evaluated at the next meeting. After completion of theTable I
Deﬁnitions of progression, improvement and unchanged status of main MOAKS features
Features described
in MOAKS
Progression Improvemen
BMLs without cyst
at baseline
- Incidence of one or more cysts or
- increase in the size of the BML or
- an increase in the number of BMLs
when there is no change in the size of
the BML
No cyst at fo
- a decrease
- a decrease
is no chan
BMLs with cyst
at baseline
One or more cysts at follow-up and:
- an increase in the size of the BML or
- an increase in the percentage of the
lesion that is BML when there is no
change in the size of the BML or
- an increase in the number of BMLs
when there is no change in the size of
the BML or percentage of the lesion
that is BML
- No cysts a
- one or mo
- a decrea
- a decrea
that is B
size of t
- a decre
there is
the perc
Cartilage defects - an increase in the percentage of full-
thickness cartilage loss or
- an increase in the size of any cartilage
loss when there was no change in the
percentage of full-thickness cartilage
loss.
- a decrease
cartilage l
- a decreas
when ther
of full-thic
Osteophytes - an increase in score for an osteophyte
scored 2 at baseline or
- a score 2 at follow-up for an
osteophyte with a score <2 at
baseline
- a decrease
2 at base
Meniscal pathologies - an increase in score of hypertrophy,
cysts, partial maceration, complete
maceration, progressive maceration,
vertical tear, horizontal tear, complex
tear, or root tear or
- an increase in the score of signal
when there is no improvement in any
of the hypertrophy, cyst, maceration
or tear scores*.
- a decrease
there is no
and tears
- a decrease
no increas
and tears
- a decreas
when ther
cyst, the o
- a decreas
there is no
maceratio
- a decrease
in hypertr
scores.
Meniscal extrusion - an increase in extrusion score - a decrease
* Since meniscal signal would then be regarded as a sequelae of the healing process..training, MRIs of 20 randomly selected knees of these ongoing
studies were scored by all trainees and the musculoskeletal radi-
ologist in order to determine reliability of the scoring.
Deﬁnitions for longitudinal change
In addition to the published deﬁnitions of the main OA features
of MOAKS5, we deﬁned and evaluated the deﬁnitions of the change
of the main MOAKS features assessed per subregion, as listed in
Table I. Contrary to structural features on radiography, improve-
ment of structural features on MRI is possible. Therefore, both
deﬁnitions of progression and improvement are given. Several
MOAKS features were not taken into account in these deﬁnitions
since progression/improvement will simply be the difference be-
tween baseline and follow-up scores (e.g., Hoffa's synovitis or
effusion-synovitis) or their role in knee OA is uncertain5.
Data collection
We applied the above mentioned deﬁnitions on knee MRI scans
acquired at baseline and after 30 months follow-up within a high-
risk cohort of middle-aged women with a body mass index
(BMI)  27 kg/m2, without knee complaints and radiographic knee
OA (K&L  2) at baseline. The design of this intervention study hast No change
llow-up and:
in the size of the BML or
in the number of BMLs when there
ge in the size of the BML
- No cyst at follow-up and
- no change in size of the BML and
- no change in number of BMLs
t follow-up or
re cysts at follow-up and:
se in the size of the BML or
se in the percentage of the lesion
ML when there is no change in the
he BML or
ase in the number of BML when
no change in the size of the BML or
entage of the lesion that is BML
- One or more cysts at follow-up and
- no change in size of the BML and
- no change in percentage of the lesion
that is BML and
- no change in the number of BMLs
in the percentage of full-thickness
oss or
e in the size of any cartilage loss
e was no change in the percentage
kness cartilage loss
- No change in the percentage of full-
thickness cartilage loss and
e no change in the size of any cartilage
loss
in score for an osteophyte scored
line
- a score <2 at baseline and follow-up
or
- no change in score for osteophytes
scored 2 at baseline
in the score of hypertrophy when
increase in the cysts, maceration
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in the score of cyst when there is
e in the hypertrophy, maceration
scores or
e in one of the maceration scores
e is no increase in hypertrophy,
ther macerations and tear scores or
e in one of the tear scores when
increase in hypertrophy, cyst,
n and other tear scores or
in signal when there is no increase
ophy, cyst, maceration and tear
- No change in score of hypertrophy,
cysts, partial maceration, complete
maceration, progressive maceration,
vertical tear, horizontal tear, complex
tear, root tear, or signal
in extrusion score - No change in extrusion score
Table II
Baseline prevalence and change of MOAKS features over 30 months
MOAKS features Medial TF joint Lateral TF joint PF joint
BMLs
- Baseline prevalence 165/687 (24%) 87/687 (13%) 342/687 (50%)
- Progression 63/687 (9.2%) 42/687 (6.1%) 151/684 (22.1%)
- No change 580/687 (84.4%) 622/687 (90.5%) 458/684 (67.0%)
- Improvement 44/687 (6.4%) 23/687 (3.3%) 75/684 (11.0%)
Cartilage defects
- Baseline prevalence 223/687 (32%) 116/687 (17%) 407/683 (60%)
- Progression 59/685 (8.6%) 41/686 (6.0%) 158/680 (23.2%)
- No change 617/685 (90.1%) 640/686 (93.3%) 502/680 (73.8%)
- Improvement 9/685 (1.3%) 5/686 (0.7%) 20/680 (2.9%)
Osteophytes
- Baseline prevalence 295/687 (43%) 198/687 (29%) 354/686 (52%)
- Progression 79/686 (11.5%) 38/686 (5.5%) 53/683 (7.8%)
- No change 605/686 (88.2%) 644/686 (93.9%) 625/683 (91.5%)
- Improvement 2/686 (0.3%) 4/686 (0.6%) 5/683 (0.7%)
Medial meniscus Lateral meniscus
Meniscal pathologies
- Baseline prevalence 405/680 (59%) 164/681 (24%)
- Progression 146/680 (21.5%) 77/681 (11.3%)
- No change 520/680 (76.5%) 585/681 (85.9%)
- Improvement 14/680 (2.1%) 19/681 (2.8%)
Meniscal extrusion
- Baseline prevalence 353/681 (51%) 43/684 (6%)
- Progression 99/681 (14.5%) 22/684 (3.2%)
- No change 564/681 (82.8%) 659/684 (96.3%)
- Improvement 18/681 (2.6%) 3/684 (0.4%)
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subjects ﬁlled-in the WOMAC questionnaire and an MRI of both
knees on a 1.5 T scanner was made. The MRI protocol included
coronal and sagittal proton density weighted sequences (slice
thickness 3.0 mm/slice gap 0.3 mm), a coronal T2-weighted Spec-
tral Presaturation by Inversion Recovery (SPIR) sequence (slice
thickness 5.0 mm/slice gap 0.5 mm), an axial dual spin-echo
sequence (slice thickness 4.5 mm/slice gap 0.5 mm), and a
sagittal 3D water selective (WATS) sequence with fat saturation
(slice thickness 1.5 mm). MRIs were scored for baseline and follow-
up time-points at the same time (order known) by JR and PvdP
using MOAKS5. As part of the training process both readers and one
additional trained team member (DvE) scored baseline and follow-
up MRIs of one randomly assigned knee every 2 weeks (15 knees
from 15 individuals in total) and discussed discrepancies in scoring
until consensus was reached. To illustrate the frequencies of change
associated with these deﬁnitions, we summed the change scores
per feature (1 for progression, 1 for improvement and 0 for no
change) into overall measures of change for themedial tibiofemoral
(TF), lateral TF joint and patellofemoral (PF) joint.
Inter-rater reliability
To determine reliability of the change in MOAKS features, these
MRIs were also scored by the experienced musculoskeletal radiol-
ogist involved (EO). Given the low prevalence of change of MOAKS
features, prevalence-adjusted bias-adjusted kappa (PABAK) statis-
tics7, rather than regular kappa statistics, and percentage agree-
ment were determined between the individual pre-consensus
change scores of the two readers (JR and PvdP) and the musculo-
skeletal radiologist scores, averaged per feature over the subregions
of MOAKS.
Results
Baseline and follow-upMRIs were available for 687 knees of 348
women (mean age 55.7 ± 3.2 years and mean BMI 32.4 ± 4.2 kg/m2
at baseline). Their average baseline WOMAC scores (0e100; higher
scores being worse) were 6.7 ± 11.4 for the pain subscale and
6.5 ± 11.0 for the function subscale. The summed overall baseline
prevalence and the change of MOAKS features, based on our deﬁ-
nitions, are given in Table II. Progression of the main MOAKS fea-
tures ranged from 3% to 23%, with higher rates in the medial than
the lateral TF joint. For progression of cartilage defects and bone
marrow lesions (BMLs), the highest rates were found in the PF joint.
Improvement was found in 0% to 11% of all knees, again with the
highest rates in the PF joint.
The average PABAK values per feature showed ‘substantial’ to
‘nearly perfect agreement’8; mean PABAK values for the change in
BMLs were 0.88 (95% CI 0.81e0.96) and 0.86 (95% CI 0.79e0.93),
with 94% and 93% agreement, respectively. Mean PABAK values for
the change in cartilage defects were 0.85 (95% CI 0.74e0.95) and
0.79 (95% CI 0.65e0.93), with 92% and 90% agreement, respectively.
Mean PABAK values for the change in osteophyte scores were 0.77
(95% CI 0.66e0.89) and 0.85 (95% CI 0.76e0.95), with 89% and 93%
agreement, respectively. Mean PABAK values for the change in
medial and lateral meniscal extrusionwere 0.78 (95% CI 0.61e0.94)
and 0.84 (95% CI 0.73e0.94), with 89% and 92% agreement,
respectively.
Discussion
For proper comparison between studies, it is important to reach
consensus on the deﬁnitions for change of OA status recorded with
the currently most advocated semi-quantitative MRI scoring tool,MOAKS5. Since the original report of MOAKS did not include deﬁ-
nitions for change, we here propose a set of deﬁnitions for the
progression and improvement of the main MOAKS features.
Improvement of MOAKS features was also deﬁned, since it is
known that several OA features seen on MRI can improve over
time9.
The set of proposed deﬁnitions showed progression and
improvement in a high risk population of women without radio-
graphic and symptomatic knee OA at baseline. Although all subjects
were free of radiographic and symptomatic knee OA at baseline,
prevalence of OA features on MRI at baseline was relatively high. As
expected, baseline prevalence and progression rates were higher in
medial than in the lateral TF joint. Somewhat more notable was the
high prevalence and the high progression rate of features within
the PF joint. Prevalence of both cartilage defects and BMLs was
approximately twice as high and these features progressed at
double the rate within the PF joint compared to the TF joint. These
data conﬁrm a previous MRI study suggesting the PF joint to be the
compartment predominantly affected by knee OA10. One should
keep in mind that the data used originate from an intervention
study, so the rate of change might not truly represent the rate of
change in an open population. However, since no effects of the
interventions on incidence of radiographic and clinical knee OA
were found11, this effect will be limited.
Despite the fact that the proposed deﬁnitions for longitudinal
change of OA features on MRI can be used to evaluate the change of
individual MOAKS features per subregion, we summed all change
scores in order to obtain a concise description of the change of the
MOAKS features over time. Obviously, summing the change of in-
dividual lesions does not reﬂect the true change over time in detail
and does not discriminate betweenmultiple lowgrade changes and
a few high grade changes. However, showing the change of these
features in a high-risk cohort was only a secondary objective in this
brief report and developing a composite change score is beyond the
scope of this report. Validation of the proposed deﬁnitions against
clinical and other structural outcomes is warranted.
Previously, determining within-grade progression showed to
have additional value in detecting longitudinal changes in semi-
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scoring system, inwhich certain feature grades reﬂect a wide range
of severity (e.g., grade 2 for size and full-thickness percentage of
cartilage defect: 10e75% of surface area). This leaves substantial
possibility for progression or improvement remaining unreﬂected
in the change in score over time. Moreover, without a within-grade
progression score, a decrease in ‘percentage of lesion that is BML’
with unchanged ‘size of the BML’ can be interpreted as both in-
crease in cyst size (progression) and a decrease in BML around a
cyst (improvement). To assess the value of a within-grade pro-
gression scorewithin theMOAKS, wewill add a three-point scale to
score overall change of the main MOAKS features over time in
another ongoing cohort13. These data will also be used to validate
the proposed deﬁnitions against the change in OA symptoms and
radiographic features of OA.
In this brief report, we propose deﬁnitions for longitudinal
semi-quantitative evaluation of OA features on MRI, assessed using
the MOAKS. We advocate uniform usage of the proposed deﬁni-
tions across studies, but welcome suggestions for optimization; in
order to enable proper comparison between future studies. Of
course, other OA features not described in this brief report, such as
effusion-synovitis or Hoffa's synovitis, might be valuable for lon-
gitudinal evaluation of OA features on MRI as well and could be
evaluated along with the described deﬁnitions.Contributions
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